Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for A2A8L1

Entry ID Method Resolution Chain Position Source
AF-A2A8L1-F1 Predicted AlphaFoldDB

72 variants for A2A8L1

Variant ID(s) Position Change Description Diseaes Association Provenance
rs221822193 77 D>E No EVA
rs3388729633 172 R>S No EVA
rs3388743276 211 A>T No EVA
rs32857544 262 A>V No EVA
rs3388743265 306 A>V No EVA
rs3388732535 335 D>Y No EVA
rs3388727084 362 T>I No EVA
rs3388721027 371 C>R No EVA
rs3410922472 379 A>V No EVA
rs3394821613 392 E>A No EVA
rs3388711940 525 C>S No EVA
rs3388724674 560 S>A No EVA
rs3388740148 568 E>G No EVA
rs3388732634 575 P>A No EVA
rs3388729710 626 W>R No EVA
rs3388721052 638 N>K No EVA
rs3388740073 642 A>D No EVA
rs3388737194 687 K>E No EVA
rs3395113805 791 V>E No EVA
rs3395113800 791 V>L No EVA
rs3388730080 834 D>N No EVA
rs3388720966 850 E>D No EVA
rs3388740154 942 M>K No EVA
rs3388730068 976 K>T No EVA
rs3388743254 990 D>G No EVA
rs3388727078 1009 P>S No EVA
rs3388737221 1036 K>M No EVA
rs3388743281 1079 G>S No EVA
rs3388737220 1090 A>V No EVA
rs3388724684 1109 I>T No EVA
rs3388729650 1121 D>E No EVA
rs3388737049 1162 Q>R No EVA
rs3388736723 1163 V>M No EVA
rs3388721046 1228 K>N No EVA
rs3388724705 1238 K>E No EVA
rs3388721006 1242 S>C No EVA
rs3388730021 1282 N>T No EVA
rs3388736437 1294 Q>* No EVA
rs3388721043 1298 R>L No EVA
rs3388736409 1369 D>H No EVA
rs3388732559 1416 R>W No EVA
rs3388735047 1480 P>S No EVA
rs580342603 1533 P>L No EVA
rs251345389 1536 A>P No EVA
rs251345389 1536 A>T No EVA
rs3388737189 1554 P>S No EVA
rs233964946 1568 T>P No EVA
rs247143094 1575 L>Q No EVA
rs3388740072 1578 T>R No EVA
rs3388724730 1579 D>N No EVA
rs32857443 1588 P>A No EVA
rs3394559261 1591 S>Y No EVA
rs3395179347 1594 I>F No EVA
rs235035250 1594 I>M No EVA
rs3388724642 1627 V>A No EVA
rs260824017 1653 P>L No EVA
rs223220111 1658 G>S No EVA
rs3388729656 1664 R>K No EVA
rs3388724716 1677 E>D No EVA
rs3388736501 1691 K>* No EVA
rs3388729700 1705 I>N No EVA
rs3388712000 1725 V>M No EVA
rs3388730090 1728 G>V No EVA
rs3388730056 1737 R>H No EVA
rs3388724724 1767 N>D No EVA
rs3388740162 1821 M>V No EVA
rs3388720975 1824 N>S No EVA
rs32856840 1917 R>P No EVA
rs3394822031 1931 P>A No EVA
rs3394559239 1932 S>N No EVA
rs3394835994 1933 H>Q No EVA
rs3413068874 1941 E>D No EVA

No associated diseases with A2A8L1

6 regional properties for A2A8L1

Type Name Position InterPro Accession
repeat Kinesin light chain repeat 362 - 403 IPR015792
repeat Tetratricopeptide repeat 253 - 286 IPR019734-1
repeat Tetratricopeptide repeat 295 - 328 IPR019734-2
repeat Tetratricopeptide repeat 337 - 370 IPR019734-3
repeat Tetratricopeptide repeat 379 - 412 IPR019734-4
repeat Tetratricopeptide repeat 464 - 497 IPR019734-5

Functions

Description
EC Number 3.6.4.12 Acting on ATP; involved in cellular and subcellular movement
Subcellular Localization
  • Nucleus
  • Chromosome
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
chromatin The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
heterochromatin A compact and highly condensed form of chromatin that is refractory to transcription.
nuclear speck A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
NuRD complex An approximately 2 MDa multi-subunit complex that exhibits ATP-dependent chromatin remodeling activity in addition to histone deacetylase (HDAC) activity, and has been shown to establish transcriptional repression of a number of target genes in vertebrates, invertebrates and fungi. Amongst its subunits, the NuRD complex contains histone deacetylases, histone binding proteins and Mi-2-like proteins.

10 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
ATP hydrolysis activity Catalysis of the reaction: ATP + H2O = ADP + H+ phosphate. ATP hydrolysis is used in some reactions as an energy source, for example to catalyze a reaction or drive transport against a concentration gradient.
ATP-dependent chromatin remodeler activity An activity, driven by ATP hydrolysis, that modulates the contacts between histones and DNA, resulting in a change in chromosome architecture within the nucleosomal array, leading to chromatin remodeling.
chromatin binding Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
DNA helicase activity Unwinding of a DNA helix, driven by ATP hydrolysis.
H3K27me3 modified histone binding Binding to a histone H3 in which the lysine residue at position 27 has been modified by trimethylation.
histone binding Binding to a histone, any of a group of water-soluble proteins found in association with the DNA of eukaryotic or archaeal chromosomes. They are involved in the condensation and coiling of chromosomes during cell division and have also been implicated in gene regulation and DNA replication. They may be chemically modified (methylated, acetlyated and others) to regulate gene transcription.
histone deacetylase binding Binding to histone deacetylase.
metal ion binding Binding to a metal ion.

10 GO annotations of biological process

Name Definition
cerebral cortex neuron differentiation The process in which a relatively unspecialized cell acquires specialized features of a neuron residing in the cerebral cortex.
chromatin remodeling A dynamic process of chromatin reorganization resulting in changes to chromatin structure. These changes allow DNA metabolic processes such as transcriptional regulation, DNA recombination, DNA repair, and DNA replication.
histone H3-K27 trimethylation The modification of histone H3 by addition of three methyl groups to lysine at position 27 of the histone.
histone H4 acetylation The modification of histone H4 by the addition of an acetyl group.
negative regulation of cell population proliferation Any process that stops, prevents or reduces the rate or extent of cell proliferation.
negative regulation of transcription by RNA polymerase II Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
positive regulation of signal transduction by p53 class mediator Any process that activates or increases the frequency, rate or extent of signal transduction by p53 class mediator.
regulation of cell differentiation Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features.
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
transcription by RNA polymerase II The synthesis of RNA from a DNA template by RNA polymerase II (RNAP II), originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).

8 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O16102 Chd3 Chromodomain-helicase-DNA-binding protein 3 Drosophila melanogaster (Fruit fly) PR
Q14839 CHD4 Chromodomain-helicase-DNA-binding protein 4 Homo sapiens (Human) PR
Q12873 CHD3 Chromodomain-helicase-DNA-binding protein 3 Homo sapiens (Human) PR
Q8TDI0 CHD5 Chromodomain-helicase-DNA-binding protein 5 Homo sapiens (Human) PR
Q6PDQ2 Chd4 Chromodomain-helicase-DNA-binding protein 4 Mus musculus (Mouse) PR
P40201 Chd1 Chromodomain-helicase-DNA-binding protein 1 Mus musculus (Mouse) PR
D3ZD32 Chd5 Chromodomain-helicase-DNA-binding protein 5 Rattus norvegicus (Rat) PR
Q22516 chd-3 Chromodomain-helicase-DNA-binding protein 3 homolog Caenorhabditis elegans PR
10 20 30 40 50 60
MRGPLGTEEE LPRLFAEEME NEEEMSEEED GGLEGFEDFF PAEPVSLPKK KPKKLKESKS
70 80 90 100 110 120
SKGKRKKKEG SNDEMSDNEE DLEEKSESEG SDYSPTKKKK KKLKEKKEKK EKKEKRKKRG
130 140 150 160 170 180
EDEDDNDDGG LKEPKSSGQL MAEWGLDDVD YLFSEDDYHT LTNYKAFSQF LRPLIAKKNP
190 200 210 220 230 240
KIPMSKMMTV LGAKWREFSA NNPFKGSSAA AAAAAVAAAV ETVTIAPPLA ISPQQVPQTL
250 260 270 280 290 300
PIRKAKTKEG KGPGVRKKNK GAKDSKKKGR GKRVAGLKFR FGGISKRKKG SSSEEDERED
310 320 330 340 350 360
SDLDNASIHS SSVRSECSAA LGKKNKRRRK KKRIDDGDGY ETDHQDYCEV CQQGGEIILC
370 380 390 400 410 420
DTCPRAYHLV CLDPELEKAP EGKWSCPHCE KEGIQWEPKD DDEEEEEGGC EEEEDDHMEF
430 440 450 460 470 480
CRVCKDGGEL LCCDACPSSY HLHCLNPPLP EIPNGEWLCP RCTCPPLKGK VQRILHWRWT
490 500 510 520 530 540
EPPAPFVVGL PGPEVEPGMP PPRPLEGIPE REFFVKWAGL SYWHCSWVKE LQLELYHTVM
550 560 570 580 590 600
YRNYQRKNDM DEPPPFDYGS GDEDGKSEKR KNKDPLYAKM EERFYRYGIK PEWMMVHRIL
610 620 630 640 650 660
NHSFDKKGDI HYLIKWKDLP YDQCTWEIDE IDIPYYDNLK QAYWGHRELM LGEDARLPKR
670 680 690 700 710 720
LVKKGKKLKD DKQEKPPDTP IVDPTVKFDK QPWYIDATGG TLHPYQLEGL NWLRFSWAQG
730 740 750 760 770 780
TDTILADEMG LGKTVQTIVF LYSLYKEGHS KGPYLVSAPL STIINWEREF EMWAPDFYVV
790 800 810 820 830 840
TYTGDKESRS VIRENEFSFE DNAIRGGKKV FRMKKEVQIK FHVLLTSYEL ITIDQAILGS
850 860 870 880 890 900
IEWACLVVDE AHRLKNNQSK FFRVLNSYKI DYKLLLTGTP LQNNLEELFH LLNFLTPERF
910 920 930 940 950 960
NNLEGFLEEF ADISKEDQIK KLHDLLGPHM LRRLKADVFK NMPAKTELIV RVELSQMQKK
970 980 990 1000 1010 1020
YYKFILTRNF EALNSKGGGN QVSLLNIMMD LKKCCNHPYL FPVAAVEAPV LPNGSYDGSS
1030 1040 1050 1060 1070 1080
LVKSSGKLML LQKMLKKLRD EGHRVLIFSQ MTKMLDLLED FLEYEGYKYE RIDGGITGGL
1090 1100 1110 1120 1130 1140
RQEAIDRFNA PGAQQFCFLL STRAGGLGIN LATADTVIIY DSDWNPHNDI QAFSRAHRIG
1150 1160 1170 1180 1190 1200
QNKKVMIYRF VTRASVEERI TQVAKRKMML THLVVRPGLG SKSGSMTKQE LDDILKFGTE
1210 1220 1230 1240 1250 1260
ELFKDDVEGM MSQGQRPTTP IPDIQSTKGG SLTAGAKKKH GSTPPGDNKD VEDSSVIHYD
1270 1280 1290 1300 1310 1320
DAAISKLLDR NQDATDDTEL QNMNEYLSSF KVAQYVVREE DGVEEVEREV IKQEENVDPD
1330 1340 1350 1360 1370 1380
YWEKLLRHHY EQQQEDLARN LGKGKRIRKQ VNYNDASQED QEWQDELSDN QSEYSIGSED
1390 1400 1410 1420 1430 1440
EDEDFEERPE GQSGRRQSRR QLKSDRDKPL PPLLARVGGN IEVLGFNARQ RKAFLNAIMR
1450 1460 1470 1480 1490 1500
WGMPPQDAFN SHWLVRDLRG KSEKEFRAYV SLFMRHLCEP GADGAETFAD GVPREGLSRQ
1510 1520 1530 1540 1550 1560
HVLTRIGVMS LVRKKVQEFE HVNGKYSTPD LVPEGAEGKK PGEVISSDPN TPVPASPAQL
1570 1580 1590 1600 1610 1620
PPAPLGLTDK MEAQLGYTDE KESGMQKPKK SLEIQTLPTA LDRVEGEDKH QSSDSKDRAR
1630 1640 1650 1660 1670 1680
EERTEEVEKA QGSPEQPLKE EVLPDKEPIP DKPELSLGHS GDFRPDDPKT EEKEPGETQQ
1690 1700 1710 1720 1730 1740
NGDREEDEEG KKEDKNGKFK FMFNIADGGF TELHTLWQNE ERAAVSSGKI YEIWHRRHDY
1750 1760 1770 1780 1790 1800
WLLAGIVTHG YARWQDIQND PRYMILNEPF KSEIHKGNYL EMKNKFLARR FKLLEQALVI
1810 1820 1830 1840 1850 1860
EEQLRRAAYL NMTQDPNHPA MALNARLAEV ECLAESHQHL SKESLAGNKP ANAVLHKVLN
1870 1880 1890 1900 1910 1920
QLEELLSDMK ADVTRLPSML SRIPPVAARL QMSERSILSR LTNRAGDPTI QQTSSRRRDF
1930 1940
PLFQRSFPAE PSHLPNPRGR EKLQPF